Piramal Pharma Q2 Results: Firm swings to profit as revenue jumps 28%, led by CDMO growth

Piramal Pharma swung to a net profit of ₹5.58 crore in Q2 FY27 from a loss of ₹99.2 crore a year earlier, as revenue grew 28% to ₹2,617 crore and EBITDA margin expanded to 13.3%.…

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.cnbctv18.com)